Upcoming webinar: Speech as a biomarker in Ataxia: What can it tell us & how should we use it?

Redenlab CSO, Adam Vogel, will be presenting at the upcoming joint webinar with the European Reference Network for rare or low prevalence complex diseases, Neurological Diseases (ERN-RND), Neuromuscular Dieseases (ERN EURO-NMD), and European Academy of Neurology. The subject of the webinar is Speech as a biomarker in Ataxia: What can it tell us & how should we use it?

Related Post

  • Posted on 15 September, 2021
    Redenlab are presenting some of their work on Parkinson’s Disease and speech at the upcoming virtual Movement Disorders Society Conference...
    • Posted on 14 September, 2021
      Over the past two decades, genomic studies have played an increasingly important role in exploring the history of our own...
      • Posted on 4 May, 2021
        Redenlab’s Chief Science Officer (Prof Adam Vogel) presents at the symposia on Facial and Vocal Markers of CNS function, “Speech...